CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA (CMPVF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmpvf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CompuGroup Medical SE & Co. KGaA (CMPVF) measures how much investors pay for each dollar of the company's trailing earnings. CMPVF's current PE ratio of 263.62x is calculated by dividing its stock price of $33.66 by its TTM earnings per share of $0.09. +543.0% elevated vs 5Y avg 41.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%42.0x
MedianQ3 · 75%130.9x
Max
At 263.62x, CMPVF's current P/E is higher than in 100% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CompuGroup Medical SE & Co. KGaAYou CMPVF | $1.7B | 263.62x | +511.2% | $0.09 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +7.2% | $3.55 |
 Biotest AG BTTAY | $943M | 66.05x | +53.2% | $0.35 |
 Drägerwerk AG & Co. KGaA DGWPF | $1.4B | 8.23x | -80.9% | $7.44 |
 Drägerwerk AG & Co. KGaA DWRKF | $1.8B | N/A | — | — |
 Kaken Pharmaceutical Co., Ltd. KKPCF | $1.0B | 72.51x | +68.1% | $56.91 |
 Kossan Rubber Industries Bhd KSRBF | $840M | 22.61x | -47.6% | $0.06 |
Industry Average 5 peers with valid PE | — | 43.13x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 52.49x | $0.55 | +101.6% | |
2024-12-31 FY2024 | 26.04x | $0.67 | -39.5% | |
2023-12-31 FY2023 | 43.04x | $0.80 | +77.0% | |
2022-12-31 FY2022 | 24.31x | $1.31 | -58.9% | |
2021-12-31 FY2021 | 59.12x | $1.16 | -14.5% | |
2020-12-31 FY2020 | 69.17x | $1.11 | +46.9% | |
2019-12-31 FY2019 | 47.10x | $1.34 | +84.6% | |
2018-12-31 FY2018 | 25.52x | $1.95 | -65.3% | |
2017-12-31 FY2017 | 73.64x | $0.64 | +64.2% | |
2016-12-31 FY2016 | 44.84x | $0.90 | +31.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CompuGroup Medical SE & Co. KGaA (CMPVF) measures how much investors pay for each dollar of the company's trailing earnings. CMPVF's current PE ratio of 263.62x is calculated by dividing its stock price of $33.66 by its TTM earnings per share of $0.09.
Frequently asked questions
CMPVF pe ratio · 6 questionsCMPVF's current PE ratio is 263.62x as of 2026-06-08, based on a stock price of $33.66 and TTM EPS of $0.09. Data sourced from Financial Modeling Prep via CMPVF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08